Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06476496 · ClinicalTrials.gov registry record · NA
Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT06476496 is a NA study that has completed, run by University of Washington. The registered enrollment target is 93 participants.
The verdict
NCT06476496, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pain in patients with long COVID. Researchers will compare pain intensity and impact on general activities over 5 months in those who receive acupuncture treatment compared to patients who are receiving usual long COVID care. Participants will complete 4 online surveys at weeks 0, 4, 8, and 20. These surveys include validated mental and physical health questionnaires. Participants who are randomly selected to receive the intervention will receive 8 acupuncture treatment sessions.
Interventions
- PROCEDURE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2025-06-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06476496
The ClinicalTrials.gov registry entry for NCT06476496 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT06476496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06476496 about?
NCT06476496 is a clinical study titled "Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID". The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pai...
What is the current status of trial NCT06476496?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2024-06-21. Estimated completion is 2025-06-23.
What interventions are being tested in trial NCT06476496?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT06476496?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.